FMCG speed meets pharma compliance. The self-medication market demands not just new speed, but platform thinking across every channel. We fill your key commercial roles precisely and fast.
Real risk management for your profitability.
To grow in the self-medication market you must combine the extreme speed of consumer goods with the hard compliance of the pharma industry, and scale digital sales models at the same time. This primarily concerns your core commercial roles. Exclusive headhunting in Germany for profiles in marketing, sales, key account management and digital scaling.
Established players often get too comfortable and manage sleeping portfolios. Meanwhile, smart digital D2C brands steal market share at a fraction of the marketing cost. An empty chair in strategic key positions carries high risk for your bottom-line responsibility. We hedge that risk through exclusive headhunting. When pressure is acute, we additionally provide short-term interim-management capacity.
The battle for the channels
The German self-medication market is turning fast. The classic pharmacy model loses ground every day. The number of bricks-and-mortar pharmacies has fallen to a historic low of 16,732 outlets.
As a research-driven pharma company you have an existential interest in this trade partner surviving. If the local pharmacy disappears, you inevitably face the hard oligopoly of drugstores and grocery retail. In the mass market, retail dictates the terms.
Even so, all relevant manufacturers currently grow primarily through mail-order. This channel already controls 24 percent of total OTC revenue. Another huge lever is internationalisation. In Asian countries the Made in Germany label, combined with real clinical evidence, carries immense value. German pharma companies with scientifically grounded portfolios have gigantic growth potential here.
The flight into food supplements
The industry is fleeing en masse into food supplements. Faster market access, no approval, only notification. In return, heavily restricted health claims and food-safety monitoring that objects to almost every second sample.
The market adopts new trends like collagen or microbiome health in months, not years. 75 percent of the adult population already use food supplements. The growth is real. But the rules of the game differ from the classic pharmaceutical business.
Health claims are tested aggressively, cease-and-desist letters are priced-in operating costs, and regulatory grey zones are part of the competition. Anyone who does not understand that is in the wrong industry. Anyone who overdoes it risks audits, product recalls and market exclusion.
To succeed under the new market conditions you need modern leaders who master both sides: FMCG speed in the product launch, pharmaceutical discipline in compliance and communication.
Where is the love?
We see every day where established brands fail. Effective heritage brands literally gather dust on the shelf. What is missing are the hybrid managers for a strategy that successfully combines pharma regulation with FMCG speed.
Brands are emotions. Are your brands love brands? This is exactly where it is decided whether a portfolio grows or slowly loses relevance and market share. Creativity and courage are the new currencies. The aggressive marketing of pure lifestyle brands often outshines established pharma brands.
Where revenue moves.
The local pharmacy loses ground, mail-order accelerates, and drugstores and grocery retail dictate the terms in the mass market. Whoever leads here must play all channels at once.
From channel to platform.
Whoever wants to succeed in the consumer-healthcare market of the future no longer thinks of channels and products in isolation, but across the board. It is not about the single ad that sells into the web shop, but about a platform ecosystem that retains the customer across the entire customer journey.
You know the problems. We fill the answer to them.
We see every day where established brands fail. It is rarely the active ingredient or the heritage that is missing. What is missing are the hybrid minds who unite FMCG speed and pharmaceutical discipline in one person.
Creativity and courage are your new currencies. The aggressive marketing of pure lifestyle brands often outshines established pharma brands. We recruit marketing leaders and senior product managers who take new paths. We bring in profiles who translate scientific data into emotional, high-impact messages for the target group. They wake sleeping brands back up.
Broad field-force coverage simply no longer pays off economically. Cross-industry benchmarks and analyses show that a single in-person field-sales visit costs between 150 and 200 euros, depending on structure. These costs completely burn up your margin in the mass market.
We place sales managers who master strict sales steering and establish new omnichannel concepts. For negotiating with the oligopolies we fill smart key account managers with measurable success on your revenue in wholesale, on Amazon and with the large mail-order chains.
Growth today no longer happens in a single channel, but on the platform. We fill chief growth officers, digital growth managers and heads of e-commerce who orchestrate channels and products across the board and retain customers long-term through subscription models, health apps and indication-related content.
For pure digital scaling we deliberately source the right profiles from beyond the pharma industry, where D2C business models and fast digital growth are at home. This is how we combine growth expertise with an understanding of the regulatory guardrails in consumer health.
The talent market in the OTC and consumer-health segment
The search for hybrid leaders who understand pharma structures and at the same time deliver at FMCG speed takes around four months on the market average. Four months that cut straight into growth in a highly seasonal business.
Pure FMCG marketers often fail in pharma structures because of the regulatory culture. Not because they are weak, but because it is a different world. The cost of a bad hire then runs to two to three times the annual salary. Those who rely on pure pharma bureaucrats, on the other hand, lose the market to faster competitors and new D2C startups in the supplements segment.
The right candidate moves confidently in both worlds. Exactly these profiles are rare, do not move via job boards and must be approached directly.
We activate passive candidates through personal direct search. We assess real substance and eliminate the culture clash through structured aptitude diagnostics before a profile reaches your desk. What unfilled roles really cost is documented in our own analyses of the economic impact for German pharma companies: revenue losses in the millions.
Our approach: plain talk.
We do without loud promises and mass processing. We analyse your individual bottleneck and your concrete objective. Do you want to revitalise a heritage brand? Are you planning growth through new licences? Are you preparing the next international step?
As a specialised boutique, we talk plainly. We do not fill quotas for internal spreadsheets. If a profile in the desired form does not exist on the market, we say so directly. We never send unsuitable candidates to artificially fill a process. We solve your problem with the best available option.
Can brand managers lead a heritage brand back into the market with modern brand thinking and relaunch experience? We critically question how marketing managers turn scientifically positioned products into real love brands. We analyse how commercial heads launch successfully in drugstore and grocery retail without alienating the core target group of pharmacists.
Our core conviction is clear: consumer health needs more FMCG speed and digital mindset, but with calculated risk. We accompany the entire process closely. This is how we secure your growth and minimise the risk of expensive bad hires. Let us define the right recruiting strategy for your plans in a personal conversation.